Drug Approval | September 29, 2023
USFDA delegation visits Divi's Laboratories’ Unit I at Choutuppal, Telangana
The delegation's visit covered a wide range of topics
The delegation's visit covered a wide range of topics
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
WINLEVI works differently from any other topical acne treatment
Glenmark will receive from Cassiopea, a subsidiary of Cosmo, the exclusive right to commercialize Winlevi in 15 EU countries
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
Kivo’s expanded platform brings compliant collaboration and intelligent process automation to emerging Regulatory, Clinical and Quality teams
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
National Health Authority (NHA) to host the two-day Arogya Manthan event in New Delhi
Will continue to own a 7.84 per cent stake in Glenmark Life Sciences with the stake reduction
Subscribe To Our Newsletter & Stay Updated
